| Title： | Chinese Ophthalmological Society guideline for initiating treatment in adults with polypoidal choroidal vasculopathy |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | Chinese ophthalmologist and policy-makers |
| Evidence classification method： | GRADE (grades of recommendations assessment, development, and evaluation) |
| Development unit： | Chinese Ophthalmological Society |
| Registration time: | 2021-01-08 |
| Registration number： | IPGRP-2021CN005 |
| Purpose of the guideline: | Promote the use of best treatment for adults with polypoidal choroidal vasculopathy, to improve clinical outcomes and patient benefit |
